发明名称 ANTI-CONNEXIN COMPOUND AND THERAPEUTIC USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To provide anti-connexin compounds and compositions useful for the treatment of various diseases, conditions and disorders in which modulation of connexins, hemichannels, and gap junctions would be benefit, and to provide methods for using these compounds and compositions as well as pharmaceutical formulations, kits, and medical devices. <P>SOLUTION: There are provided methods and compositions for modulating the activity of connexins, for example, for use for the treatment of cardiovascular, vascular, neurological, wounds and other indications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated with diseases and disorders where localized disruption in direct cell-cell communication or prevention of hemichannel opening is desirable. In one aspect, compounds, compositions and methods for treating a subject with a vascular disorder are provided. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012107065(A) 申请公布日期 2012.06.07
申请号 JP20120047133 申请日期 2012.03.02
申请人 CODA THERAPEUTICS LTD 发明人 GREEN COLIN R;BECKER DAVID L
分类号 A61K45/00;A61K31/7088;A61K31/712;A61K31/7125;A61K31/713;A61K38/00;A61K38/22;A61K38/43;A61K48/00;A61P1/02;A61P1/04;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P9/12;A61P17/02;A61P17/06;A61P19/02;A61P21/04;A61P25/00;A61P29/00;A61P31/04;A61P37/02;C07K14/475;C07K14/52;C12N15/113 主分类号 A61K45/00
代理机构 代理人
主权项
地址